Results for "Understanding Pharmaceutical Distribution"
HDA’s Davis Shares 2022 Strategic Priorities Under Increased Awareness of Supply Chains
Events spanning COVID-19 vaccine distribution to shipping containers held up at port have made the supply chain a “kitchen-table” issue during the past year. Many industries experienced notable disruptions in their delivery of goods and supplies; however, as noted by President and CEO Chip Davis, “[P]harmacies, health systems and physicians’ offices, more than 180,000 across the country, remain stocked with the lifesaving medications and vaccines patients need. That didn’t happen by accident.” Davis’ perspective was featured alongside healthcare supply chain association leaders as part of Chain Drug Review’s annual “Pharmacy Outlook” feature.
Health Delivered, Explained: How Do Medicines Reach Patients?
Most Americans never think about how a prescription gets from a manufacturing facility to their pharmacy counter. They don’t need to, because healthcare distributors work quietly and consistently to move millions of medicines every day. In this new series, we will answer the questions we hear most often about what distributors do and why it matters. First up: How medicines reach patients.
DSCSA, the 2023 Requirements and EPCIS
Since the enactment of the Drug Supply Chain Security Act in 2013, members of the pharmaceutical supply chain have undertaken efforts to meet each of the major milestones contained within the statute’s 10-year timeline to further secure the safety of the products being distributed. The industry’s progress to 2023 interoperability was top of mind as supply chain and other stakeholders came together at HDA’s recent Traceability Online Seminar.
